Chemical structure indices in in silico molecular design

Scientia Pharmaceutica

Volumn 76, Issue 2, 2008, Pages 101-132

  Prabhakar, Yenamandra S ^a   Gupta, Manish K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Chemical structure indices; In silico drug design; Molecular modeling; QSAR

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; PYRIMIDINE DERIVATIVE;

CHIRALITY; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPUTER MODEL; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SOLUBILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; MOLECULAR MODEL; PHARMACOPHORE; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY; REVIEW;

EID: 46249129182     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0804-12     Document Type: Review

References (126)

1. Jorgensen WL. The many roles of computation in drug discovery. Science. 2004; 303: 1813-1818. [doi:10.1126/science.1096361]
2. Kubinyi H. QSAR and 3D QSAR in drug design Part 2: applications and problems. Drug Discov Today. 1997; 2: 538-546 and references cited therein. [doi:10.1016/S1359-6446(97)01084-2]
3. Perkins R, Fang H, Tong W, Welsh WJ. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology. Environ Toxicol Chem. 2003; 22: 1666-1679. [doi:10.1897/01-171]
4. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nature Rev Drug Discov. 2004; 3: 935-949. [doi:10.1038/nrd1549]
5. Waszkowycz B, Perkins TDJ, Sykes RA, Li J. Large-scale virtual screening for discovering leads in the postgenomic era. IBM Syst J. 2001; 40: 360-376.
6. Hillisch A, Pineda LF, Hilgenfeld R. Utility of homology models in the drug discovery process. Drug Discov Today. 2004; 9: 659-669. [doi:10.1016/S1359-6446(04)03196-4]
7. Gozalbes R, Doucet JP, Derouin F. Application of topological descriptors in QSAR and drug design: history and new trends. Curr Drug Targets Infect Disord. 2002; 2: 93-102. [doi:10.2174/1568005024605909]
8. Hu Q-N, Liang Y-Z, Fang K-T. The matrix expression, topological index and atomic attribute of molecular topological structure. J Data Science. 2003; 1: 361-389.
9. Yamashita F, Hashida M. In silico approaches for predicting ADME properties of drugs. Drug Metab Pharmacokinet. 2004; 19: 327-338. [doi:10.2133/dmpk.19.327]
10. Dearden JC. In silico prediction of drug toxicity. J Comput Aided Mol Des. 2003; 17: 119-127. [doi:10.1023/A:1025361621494]
11. Ekins S, Wrighton SA. Application of In silico approaches to predicting drug-drug interactions. J Pharmacol Toxicol Methods. 2001; 45: 65-69. [doi:10.1016/S1056-8719(01)00119-8]
12. Muegge I. Selection criteria for drug-like compounds. Med Res Rev. 2003; 23: 302-321. [doi:10.1002/med.10041]
13. Weaver DC. Applying data mining techniques to library design, lead generation and lead optimization. Curr Opin Chem Biol. 2004; 8: 264-270. [doi:10.1016/j.cbpa.2004.04.005]
14. Walters WP, Goldman BB. Feature selection in quantitative structure-activity relationships. Curr Opin Drug Discov Devel. 2005; 8: 329-333.
15. Fattori D. Molecular recognition: the fragment approach in lead generation. Drug Discov Today. 2004; 9: 229-238. [doi:10.1016/S1359-6446(03) 03007-1]
16. Hoeben FJ, Jonkheijm P, Meijer EW, Schenning AP. About supramolecular assemblies of pi-conjugated systems. Chem Rev. 2005; 105: 1491-1546. [doi:10.1021/cr030070z]
17. Hansch C, Fujita T. ρ-σ-Π Analysis. A Method for the correlation of biological activity and chemical structure. J Am Chem Soc. 1964; 86: 1616-1626. [doi:10.1021/ja01062a035]
18. Free S M Jr, Wilson JW. A mathematical approach to structure-activity studies. J Med Chem. 1964; 7: 395-399. [doi:10.1021/jm00334a001]
19. Hansch C, Sammes PG, Taylor JB, Ramsden CA, editors. In: Comprehensive medicinal chemistry: The rational design, mechanistic study and therapeutic application of chemical compounds. Volume 4, London: Pergamon Press, 1990.
20. Hansch C, Leo A. Substituent constants for correlation analysis in chemistry and biology. NewYork: Wiley-Interscience, 1979 and references cited therein.
21. Taft RW. Polar and steric substituent constants for aliphatic and o-benzoate groups from rates of esterification and hydrolysis of esters. J Am Chem Soc. 1952; 74: 3120-3128. [doi:10.1021/ja01132a049]
22. Hammett LP. The effect of structure upon the reactions of organic compounds. Benzene derivatives. J Am Chem Soc. 1937; 59: 96-103. [doi:10.1021/ja01280a022]
23. Minick DJ, Frenz JH, Patrick MA, Brent DA. A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography. J Med Chem. 1988; 31: 1923-1933. [doi:10.1021/jm00118a010]
24. Rekker RF. The hydrophobic fragmental constants: Its derivation and applications - A means of characterizing membrane systems. New York: Elsevier, 1977.
25. Rekker RF, De Kort HM. The hydrophobic fragmental constants; an extension to a 1000 data point set. Eur J Med Chem-Chim Ther. 1979; 14: 479-488.
26. Viswanadhan VN, Ghose AK, Revankar GR, Robins RK. Atomic physicochemical parameters for three-dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J Chem Inf Comput Sci. 1989; 29:163-172 and references cited therein. [doi:10.1021/ci00063a006]
27. Kantola A, Villar HO, Loew GH. Atom based parameterization for a conformationally dependent hydrophobic index. J Comput Chem. 1991;12:681-689. [doi:10.1002/jcc.540120605]
28. Klopman G, Iroff LD. Calculation of partition coefficients by the charge density method. J Comput Chem 1981; 2: 157-160. [doi:10.1002/jcc.540020204]
29. Hopfinger AJ, Battershell RD. Application of SCAP to drug design. 1. Prediction of octanol-water partition coefficients using solvent-dependent conformational analyses. J Med Chem 1976; 19: 569-573. [doi:10.1021/jm00227a001]
30. Bodor N, Gabanyi Z, Wong C-K. A new method for the estimation of partition coefficient. J Am Chem Soc 1989; 111: 3783-3786. [doi:10.1021/ ja00193a003]
31. Mayer JM, van der Waterbeemd H, Testa B. A comparison between the hydrophobic fragmental method of Rekker and Leo. Eur J Med Chem-Chim Ther. 1982; 17: 17-25.
32. oct from structures. Chem Rev. 1993; 93: 1281-1306. [doi:10.1021/cr00020a001]
33. Tetko IV, Poda GI. Application of ALOGPS 2.1 to predict logD distribution coefficient for Pfizer proprietary compounds. J Med Chem 2004; 47: 5601-5604 and references cited therein. [doi:10.1021/jm049509l]
34. Taft RW. The general nature of the proportionality of polar effects of substituent groups in organic chemistry. J Am Chem Soc 1953; 75: 4231-4238. [doi:10.1021/ja01113a027]
35. Swain CG, Lupton EC. Field and resonance components of substituent effects. J Am Chem Soc 1968; 90: 4328-4337. [doi:10.1021/ja01018a024]
36. Beger RD, Buzatu DA, Wilkes JG, Lay JO Jr. (13)C NMR quantitative spectrometric data-activity relationship (QSDAR) models of steroids binding the aromatase enzyme. J Chem Inf Comput Sci. 2001; 41: 1360-1366. [doi:10.1021/ci010285e]
37. Ariens EJ, editor. In: Drug Design. Volume 7. NewYork: Acadmic Press, 1976: 165-207.
38. Charton M. Steric effects. 7. Additional V constants. J Org Chem. 1976; 41: 2217-2220. [doi:10.1021/jo00874a035]
39. Gupta SP, Prabhakar YS. Importance of van der Waals Volume in QSAR studies for Drugs. J Sci Ind Res. 1985; 44: 189-198.
40. Cohen NC, Blaney JM, Humblet C, Gund P, Barry DC. Molecular modeling software and methods for medicinal chemistry. J Med Chem. 1990; 33: 883-894. [doi:10.1021/jm00165a001]
41. Young DC. Computational chemistry (online book). John Wiley & Sons, Inc. 2002: 19-41; www.interscience.wiley.com. [doi:10.1002/0471220655]
42. Pople JA, Head-Gordon M, Fox DJ, Raghavachari K, Curtiss LA. Gaussian-1 theory: a general procedure for prediction of molecular energies. J Chem Phys. 1989; 90: 5622-5629. [doi:10.1063/1.456415]
43. Schmidt MW, Baldridge KK, Boatz, JA, Elbert ST, Gordon MS, Jensen JH, Koseki S, Matsunaga N, Nguyen KA, Su S, Windus TL, Dupuis M, Montgomery JA Jr. The general atomic and molecular electronic structure system. J Comput Chem. 1993; 14: 1347-1363. [doi:10.1002/jcc.540141112]
44. Pearlman DA, Case DA, Caldwell JW, Ross WR, Cheatham TE, DeBolt S, Ferguson D, Seibel G, Kollman P. AMBER, a computer program for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to elucidate the structures and energies of molecules. Comp Phys Commun. 1995; 91: 1-41. [doi:10.1016/0010-4655(95)00041-D]
45. Case DA, Cheatham TE III, Darden T, Gohlke H, Luo R, Merz Jr. KM, Onufriev A, Simmerling C, Wang B, Woods RJ. The Amber biomolecular simulation programs. J Comput Chem 2005; 26: 1668-1688. [doi:10.1002/jcc.20290]
46. Halgren TA. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem. 1996; 17: 490-519 and references cited therein. [doi:10.1002/(SICI)1096-987X(199604)17:5/ 6〈490::AID-JCC1〉3.0.CO;2-P]
47. Karelson M, Lobanov VS, Katritzky AR. Quantum-chemical descriptors in QSAR/QSPR studies. Chem Rev. 1996; 96: 1027-1043 and references cited herein. [doi:10.1021/cr950202r]
48. Hosoya, H. A newly proposed quantity characterizing the topological nature of structural isomers of saturated hydrocarbons. Bull Chem Soc Japan. 1971; 44: 2332-2339.
49. Randic M. On characterization of molecular branching. J Am Chem Soc. 1975; 97: 6609-6015. [doi:10.1021/ja00856a001]
50. Kier LB, Hall LH. Molecular connectivity in chemistry and drug research. New York: Academic Press, 1976.
51. Basak SC, Harriss DK, Magnuson VR. POLLY, University of Minnesota: Duluth, MN, 1988.
52. Molconn-Z, ver. 2.07, eduSoft Lc, a Virginia Corporation, Ashland, VA 23005 USA; www.edusoft-lc.com.
53. Estrada E. Spectral moments of the edge adjacency matrix in molecular graphs. 3. Molecules containing cycles. J Chem Inf Comput Sci. 1998; 38: 23-27 and references cited therein. [doi:10.1021/ci970030u]
54. Estrada E, Gutierrez Y, González H. Modeling diamagnetic and magnetooptic properties of organic compounds with the TOSS-MODE approach. J Chem Inf Comput Sci. 2000; 40: 1386-1399. [doi:10.1021/ci000041e]
55. Katritzky AR, Lobnov V, Karelson M. CODESSA (Comprehensive Descriptors for Structural and Statistical Analysis) 1994, University of Florida, Gainesville, FL. www.codessa-pro.com.
56. Katritzky AR, Perumal S, Petrukhin R, Kleinpeter E. CODESSA-based theoretical QSPR model for hydantoin HPLC-RT lipophilicities. J Chem Inf Comput Sci. 2001; 41: 569-574. [doi:10.1021/ci000099t]
57. DRAGON software by Todeschini R, Consonni V, Mauri A, Pavan M. Milano, Italy.
58. Li ZR, Han LY, Xue Y, Yap CW, Li H, Jiang L, Chen YZ. MODEL - molecular descriptor lab: A web-based server for computing structural and physicochemical features of compounds. Biotechnol Bioeng. 2007; 97: 389-396. [doi:10.1002/bit.21214]
59. Basak SC, Mills D. Development of quantitative structure-activity relationship models for vapor pressure estimation using computed molecular descriptors. Arkivoc. 2005; 10: 308-320.
60. Broto P, Moreau G, Vandycke C. Molecular structures: perception, autocorrelation descriptors and SAR studies. Eur J Med Chem-Chim Ther. 1984; 19: 71-78.
61. Clementi S, Cruciani G, Riganelli D, Valigi R, Costantino G, Baroni M, Wold S. Autocorrelation as a tool for a congruent description of molecules in 3D-QSAR studies. Pharm Pharmacol Lett. 1993; 3: 5-8.
62. Wagener M, Sadowski J, Gasteiger J. Autocorrelation of molecular surface properties for modeling corticosteroid binding globulin and cytosolic Ah receptor activity by neural networks. J Am Chem Soc. 1995; 117: 7769-7775. [doi:10.1021/ja00134a023]
63. Balaban AT, Ciubotariu D, Medeleanu M. Topological indices and real number vertex invariants based on graph eigenvalues or eigenvectors. J Chem Inf Comput Sci. 1991; 31: 517-523. [doi:10.1021/ci00004a014]
64. Hemmer MC, Steinhauer V, Gasteiger J. Deriving the 3D structure of organic molecules from their infrared spectra. Vib Spectrosc. 1999; 19: 151-164. [doi:10.1016/S0924-2031(99)00014-4]
65. Schuur JH, Selzer P, Gasteiger J. The coding of the three-dimensional structure of molecules by molecular transforms and its application to structure-spectra correlations and studies of biological activity. J Chem Inf Comput Sci. 1996; 36: 334-344. [doi:10.1021/ci950164c]
66. Consonni V, Todeschini R, Pavan M, Gramatica P. Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 2. Application of the novel 3D molecular descriptors to QSAR/QSPRStudies. J Chem Inf Comput Sci. 2002; 42: 693-705 and references cited therein. [doi:10.1021/ci0155053]
67. Mihalic Z, Nikolic S, Trinajstic N. Comparative study of molecular descriptors derived from the distance matrix. J Chem Inf Comput Sci. 1992; 32: 28-37. [doi:10.1021/ci00005a005]
68. Bath PA, Poirrette AR, Willett P, Allen FH. The extent of the relationship between the graph-theoretical and the geometrical shape coefficients of chemical compounds. J Chem Inf Comput Sci. 1995; 35: 714-716. [doi:10.1021/ci00026a007]
69. Katritzky AR, Mu L, Lobanov VS, Karelson M. Correlation of boiling points with molecular structure. 1. A training set of 298 diverse organics and a test set of 9 simple inorganics. J Phys Chem. 1996; 100: 10400-10407. [doi:10.1021/jp953224q]
70. Galvez J. Prediction of molecular volume and surface of alkanes by molecular topology. J Chem Inf Comput Sci. 2003; 43: 1231-1239. [doi:10.1021/ci034036x]
71. Torrens F. Valence topological charge-transfer indices for dipole moments. Mol Divers. 2004; 8: 365-370. [doi:10.1023/B:MODI.0000047508.78271.b1]
72. Bergstrom CA, Wassvik CM, Norinder U, Luthman K, Artursson P. Global and local computational models for aqueous solubility prediction of drug-like molecules. J Chem Inf Comput Sci. 2004; 44: 1477-1488. [doi:10.1021/ci049909h]
73. Gupta MK, Sagar R, Shaw AK, Prabhakar YS. CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols-topological descriptors in modeling the activity. Bioorg Med Chem. 2005; 13: 343-351. [doi:10.1016/j.bmc.2004.10.025]
74. Prabhakar YS, Gupta MK, Roy N, Venkateswarlu Y. A high dimensional QSAR study on the aldose reductase inhibitory activity of some flavones: topological descriptors in modeling the activity. J Chem Inf Model. 2006; 46: 86-92. [doi:10.1021/ci050060u]
75. 3 adenosine receptors. Bioorg Med Chem Lett. 2006; 16: 1291-1296. [doi:10.1016/j.bmcl.2005. 11.063]
76. Saquib M, Gupta MK, Sagar R, Prabhakar YS, Shaw AK, Kumar R, Maulik PR, Gaikwad AN, Sinha S, Srivastava AK, Chaturvedi V, Srivastava R, Srivastava BS. C-3 alkyl/ arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: Synthesis, biological evaluation and QSAR study. J Med Chem. 2007; 50: 2942-2950. [doi:10.1021/jm070110h]
77. Panaye A, Doucet JP, Fanpp BT. Topological approach of carbon-13 NMR spectral simulation: application to fuzzy substructures. J Chem Inf Comput Sci. 1993; 33: 258-265. [doi:10.1021/ci00012a012]
78. Benight AS, Pancoska P, Owczarzy R, Vallone PM, Nesetril J, Riccelli PV. Calculating sequence-dependent melting stability of duplex DNA oligomers and multiplex sequence analysis by graphs. Method Enzymol. 2001; 340: 165-192. [doi:10.1016/S0076-6879(01)40422-8]
79. Freudenberg J, Zimmer R, Hanisch D, Lengauer T. A hypergraph-based method for unification of existing protein structure- and sequence-families. In Silico Biology. 2002; 2: 339-349.
80. Xu Y, Xu D, Gabow HN. Protein domain decomposition using a graph-theoretic approach. Bioinformatics. 2000; 16: 1091-1104. [doi:10.1093/bioinformatics/16.12.1091]
81. Jacobs DJ, Rader AJ, Kuhn LA, Thorpe MF. Protein flexibility predictions using graph theory. Proteins. 2001; 44: 150-165. [doi:10.1002/prot.1081]
82. Milan R. A graph theoretical characterization of proteomic maps. Int J Quantum Chem. 2002; 90: 848-858. [doi:10.1002/qua.10060]
83. Hall LH, Dailey RS, Kier LB. Design of molecules from quantitative structure-activity relationship models. 3. Role of higher order path counts: path 3. J Chem Inf Comput Sci. 1993; 33: 598-603 and references cited therein. [doi:10.1021/ci00014a012]
84. Klopman G, Raychaudhury C. Vartex indices of molecular graphs in structure-activity relationships: A study of the convulsant-anticonvulsant activity of barbiturates and the carcinogenicity of unsubstituted aromatic hydrocarbons. J Chem Inf Comput Sci. 1990; 30: 12-19. [doi:10.1021/ci00065a004]
85. Gordeeva EV, Molchanova MS, Zefirov NS. General methodology and computer program for the exhaustive restoring of chemical structures by molecular connectivity indexes. Solution of the inverse problem in QSAR/QSPR. Tetrahedron Comput Methodol. 1990; 3: 389-415. [doi:10.1016/0898-5529(90)90066-H]
86. Contreras ML, Valdivia R, Rozas R. Exhaustive generation of organic isomers.1. Acyclic structures. J Chem Inf Comput Sci. 1992; 32: 323-330. [doi:10.1021/ci00008a011]
87. Kvasnicka V, Pospichal J. Simulated annealing construction of molecular graphs with required properties. J Chem Inf Comput Sci. 1996; 36: 516-526. [doi:10.1021/ci9500703]
88. Churchwell CJ, Rintoul MD, Martin S, Visco Jr. DP, Kotu A, Larson RS, Sillerud LO, Brown DC, Faulon J-L. The signature molecular descriptor: 3. Inverse-quantitative structure-activity relationship of ICAM-1 inhibitory peptides. J Mol Graph Model. 2004; 22: 263-273 and references cited therein. [doi:10.1016/j.jmgm.2003.10.002]
89. Skvortsova MI, Fedyaev KS, Palyulin VA, Zefirov NS. Molecular design of chemical compounds with prescribed properties from QSAR models containing the Hosoya index. Internet Electron J Mol Des. 2003; 2: 70-85 and references cited therein.
90. Schultz HP, Schultz EB, Schultz TP. Topological organic chemistry. 9. Graph theory and molecular topological indices of stereoisomeric organic compounds. J Chem Inf Comput Sci. 1995; 35: 864-870. [doi:10.1021/ci00027a011]
91. Julian-Ortiz JV, Gregorio Alaponta C, Rios-Santamarinaa I, Garcia-Domenecha R, Galveza J. Prediction of properties of chiral compounds by molecular topology. J Mol Graph Model. 1998; 16: 14-18. [doi:10.1016/S1093- 3263(98)00013-8]
92. Prabhakar YS. Analysis of tetrahedral carbon in QSAR sudies. A case study using -hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. J Chem Inf Comput Sci. 1999; 39: 650-653. [doi:10.1021/ci980047s]
93. Golbraikh A, Bonchev D, Tropsha A. Novel chirality descriptors derived from molecular topology. J Chem Inf Comput Sci. 2001; 41: 147-158. [doi:10.1021/ci000082a]
94. Golbraikh A, Bonchev D, Tropsha A. Novel ZE-isomerism descriptors derived from molecula topology and their application to QSAR analysis. J Chem Inf Comput Sci. 2002; 42:769-787. [doi:10.1021/ci0103469]
95. Randic M. Graph theoretical descriptors of two-dimensional chirality with possible extension to three-dimensional chirality. J Chem Inf Comput Sci. 2001; 41: 639-649. [doi:10.1021/ci000115m]
96. Rassat A, Laszlo I, Fowler PW. Topological rotational strengths as chirality descriptors for fullerenes. Chemistry. 2003; 9: 644-651. [doi:10.1002/chem.200390072]
97. Kovatcheva A, Golbraikh A, Oloff S, Feng J, Zheng W, Tropsha A. QSAR modeling of datasets with enantioselective compounds using chirality sensitive molecular descriptors. SAR QSAR Environ Res. 2005; 16: 93-102. [doi:10.1080/10629360412331319844]
98. Randic M. Novel graph theoretical approach to heteroatoms in quantitative structure-activity relationships. Chemom Intell Lab Syst. 1991; 10: 213-227. [doi:10.1016/0169-7439(91)80051-Q]
99. Kier LB, Hall LH. Molecular connectivity VII: specific treatment of heteroatoms. J Pharm Sci. 1976; 65: 1806-1809.
100. Krenkel G, Castro EA, Toropov AA. Improved molecular descriptors based on the optimization of correlation weights of local graphs invariants. Int J Mol Sci. 2001; 2: 57-65.
101. Pogliani L. Modeling purines and pyrimidines with the linear combination of connectivity indices-molecular connectivity "LCCI-MC" method. J Chem Inf Comput Sci. 1996; 36: 1082-1091. [doi:10.1021/ci960020d]
102. Pogliani L. Modeling properties with higher-level molecular connectivity descriptors. J Chem Inf Comput Sci. 1999; 39: 104-111. [doi:10.1021/ci980054g]
103. Vidal D, Thormann M, Pons M. LINGO, an efficient holographic text based method to calculate biophysical properties and intermolecular similarities. J Chem Inf Model. 2005; 45: 386-393. [doi:10.1021/ci0496797]
104. Toropov AA, Nesterov IV, Nabiev OM. QSAR modeling of dihydrofolate reductase inhibitory activity by correlation weighting of nearest neighboring codes. J Mol Struct. (THEOCHEM) 2003; 622: 269-273. [doi:10.1016/S0166-1280(02) 00662-0]
105. Toropov AA, Toropova AP, Nesterov IV, Nabiev OM. Comparison of QSAR models of anti-HIV1 potencies based on labeled hydrogen filled graph and graph of atomic orbitals. J Mol Struct (THEOCHEM). 2003; 640: 175-181. [doi:10.1016/j.theochem.2003.08.127]
106. Randic M, Mills D, Basak SC. On characterization of physical properties of amino acids. Int J Quant Chem. 2000; 80: 1199-1209. [doi:10.1002/1097- 461X(2000)80:6〈1199::AID-QUA6〉3.0.CO;2-M]
107. Daylight Chemical Information Systems, Inc. Daylight Clustering Manual; www.daylight.com.
108. Durant JL, Leland BA, Henry DR, Nourse JG. Reoptimization of MDL keys for use in drug discovery. J Chem Inf Comput Sci. 2002; 42: 1273-1280. [doi:10.1021/ci010132r]
109. Barnard Chemical Information Ltd. 46 Uppergate Road, Sheffield S6 6BX, UK.
110. Brown N, McKay B, Gasteiger J. Fingal: A novel approach to geometric fingerprinting and a comparative study of its application to 3D-QSAR modeling. QSAR Comb Sci. 2005; 24: 480-484. [doi:10.1002/qsar.200430923]
111. Haigh JA, Pickup BT, Grant JA, Nicholls A. Small molecule shape-fingerprints. J Chem Inf Model. 2005; 45: 673-684. [doi:10.1021/ci049651v]
112. Willett P, Barnard JM, Downs GM. Chemical similarity searching. J Chem Inf Comput Sci. 1998; 38: 983-996. [doi:10.1021/ci9800211]
113. McGregor MJ, Muskal SM. Pharmacophore fingerprinting. 1. Application to QSAR and focused library design. J Chem Inf Comput Sci. 1999; 39: 569-574. [doi:10.1021/ci980159j]
114. Downs GM, Barnard JM. Clustering methods and their uses in computational chemistry. Rev Comput Chem. 2002; 18: 1-40. [doi:10.1002/0471433519.ch1]
115. Winkler DA, Burden FR. Holographic QSAR of benzodiazepines. Quant Struct-Act Relat. 1998; 17: 224-231. [doi:10.1002/(SICI)1521-3838(199806)17: 03〈224::AID-QSAR224〉3.0.CO;2-6]
116. Schwaha R, Ecker GF. The similarity principle - new trends and applications in ligand-based drug discovery and admet profiling. Sci Pharm. 2008; 76: 5-18. [doi:10.3797/scipharm.0802-05]
117. Bursi R, Dao T, van Wijk T, de Gooyer M, Kellenbach E, Verwer P. Comparative spectra analysis (CoSA): spectra as three-dimensional molecular descriptors for the prediction of biological activities. J Chem Inf Comput Sci. 1999; 39: 861-867. [doi:10.1021/ci990038z]
118. Ferguson AM, Heritage T, Jonathon P, Pack SE, Phillips L, Rogan J, Snaith PJ. EVA: A new theoretically based molecular descriptor for use in QSAR/QSPR analysis. J Comput Aid Mol Des. 1997; 11: 143-152. [doi:10.1023/A:1008026308790]
119. Langer T, Krovat EM. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads. Curr Opin Drug Discov Devel. 2003; 6: 370-376.
120. Cramer RD III, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988; 110: 5959-5967. [doi:10.1021/ja00226a005]
121. Silverman BD, Platt DE. CoMMA: Comparative molecular moment analysis. 3D-QSAR without molecular superposition. J Med Chem. 1996; 39: 2129-2140. [doi:10.1021/jm950589q]
122. Cramer RD, Wendt B. Pushing the boundaries of 3D-QSAR. J Comput Aided Mol Des. 2007; 21: 23-32. [doi:10.1007/s10822-006-9100-0]
123. Fujita T. Recent success stories leading to commercializable bioactive compounds with the aid of traditional QSAR procedures. Quant Struct-Act Relat. 1997; 16: 107-112. [doi:10.1002/qsar.19970160202]
124. Guba W, Neidhart W, Nettekoven M. Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design. Bioorg Med Chem Lett. 2005; 15: 1599-1603. [doi:10.1016/j.bmcl.2005.01. 063]
125. Nettekoven M, Guba W, Neidhart W, Mattei P, Pflieger P, Roche O, Taylor S. Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor. Bioorg Med Chem Lett. 2005; 15: 3446-3449. [doi:10.1016/j.bmcl.2005.05.009]
126. Foye WO, Lemke TL, Williams DA. Editors. Structural features and pharmacologic activity. In: Principles of Medicinal Chemistry. N Delhi: BI Waverly Pvt Ltd, 1995: 25-49.